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ABSTRACT
Introduction: Hair shedding is a common
consequence of the normal hair cycle that
changes with internal and external factors.
Female pattern hair loss (FPHL) is difficult to
assess in terms of shedding severity as the
conscious perception of hair shedding varies
according to each individual, and most utilized
methods are semi-invasive or very time
consuming. In this study, we establish and
validate a hair-shedding scale for women with
thick hair of different lengths.
Methods: A visual analog scale was developed
for thick hair of short, medium, and long
lengths by dividing a bundle of hairs of each
length into nine piles of increasing hair amount
that were then photographed and arranged in
order of size. Twenty women with no FPHL with
each length of hair (60 total) were asked to
select the photographed hair bundle that best
correlated with the amount of hair they shed on
an average day. A total of 94 women with FPHL
with excessive shedding were then asked to
repeat the same process.
Results: Women with no FPHL and short,
medium and long hair had mean shedding
scores of 2.5, 2.35 and 2.4, respectively. Women
with FPHL and short, medium and long hair
had mean shedding scores of 7.25, 7.0 and 7.14,
respectively. Statistically significant Spearman’s
q coefficient and j coefficient demonstrated
correlation and inter-observer reliability.
Conclusion: Our results show that women with
FPHL not only shed considerable hair more
than women with no FPHL, but that this
hair-shedding visual scale is a fast and effective
method of evaluating hair-shedding amounts in
an office setting.
Keywords: Alopecia; Female pattern hair loss;
FPHL; Hair loss; Hair shedding; Scale; Shedding;
Telogen effluvium; Thick hair; Visual analogue
scale
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INTRODUCTION
The hair cycle consists of multiple phases: ana-
gen (the growing phase), catagen (the regression
phase), telogen (the resting phase), exogen (the
shedding phase) and kenogen (the empty phase)
[1–3]. The anagen phase lasts from 2 to 6 years
and is the phase of active growth that determines
the length of the hair. While each follicle is in its
own stage of the cycle at any given time, most
scalp hairs are in the anagen phase in the normal
hair cycle. After anagen, the hair follicle enters
the transitional catagen phase as it shrinks and
detaches from the dermal papilla. The hair then
rests in the telogen phase for about 3 months
until it is eventually released and shed as the new
hair continues to grow during exogen. The
kenogen phase indicates the period of the hair
cycle in which the hair follicle remains empty
after the telogen hair has shed and before a new
anagen hair emerges [4, 5]. Although the keno-
gen phase is observed in normal scalp, its dura-
tion and frequency are increased in androgenetic
alopecia [6].
Hair shedding is, therefore, a common conse-
quence of the normal hair cycle. The amount of
hairs that are shed depends on several internal
and external factors, and the conscious percep-
tion of hair shedding can vary by individual. It is
logical to think that the amount of shedding
should also depend on the total hair density and
that women with thin hair and reduced hair
density, as for instance women with advanced
female pattern hair loss (FPHL), shed less than
women with early FPHL or women with normal
hair density, whether or not active hair loss is
taking place. However, there are no specific stud-
ies on hair shedding in womenwith severe FPHL.
Differentiating between normal hair shedding
and that which is excessive can be challenging, as
most patients complain that they shedmore than
normal, but thedoctor rarely sees theamount that
is shed. Common diseases causing hair loss in
women include FPHL, acute and chronic telogen
effluvium, alopecia areata, anagen effluvium, and
cicatricial alopecias.
Female pattern hair loss is the most common
disorder associatedwith hair shedding and ismore
prevalent with increasing age [7–10]. The term
FPHL is preferred to androgenetic alopecia as the
majority of women with FPHL do not have
increased levels ofmale hormones, nor other signs
of increasedandrogeneffect, anddonot respondto
anti-androgens with dramatic hair regrowth [11].
The pathogenesis of FPHL involves
miniaturization and shortened anagen duration
leading to an increase in hair shedding. Patients
with FPHL may consult a doctor because they
notice hair thinning, particularly over the
mid-frontal scalp or because they notice
increased hair shedding. In fact, FPHL is often
precipitated and exacerbated by conditions that
cause telogen effluvium, such as drugs, acute
stressors, weight loss, and partum. Sinclair et al.
found that 60% of women presenting with
increased hair shedding, without any dis-
cernible thinning or reduction in hair density,
had androgenetic alopecia on scalp biopsy [12].
Early diagnosis of FPHL is very important in
order to prevent disease progression while
miniaturization is still in the initial phases and
possibly reversible. This can be achieved by
dermoscopy, which is very helpful in diagnos-
ing early disease.
An important distinguishing feature of FPHL
on dermoscopy is the presence of hairs with dif-
ferent thickness (hair diameter diversity), which
reflect the miniaturization process [13, 14].
Another typical dermoscopic feature of FPHL is
the presence of more than six thin short
regrowing hairs in the frontal scalp. Dermoscopy
also distinguishes FPHL from chronic telogen
effluvium (CTE), another disorder characterized
by increased shedding and loss of volume that is
often difficult to assess with objective methods.
The pull test is the most utilized test to assess
hair shedding in clinical practice [15]; however,
it is not very sensitive and most women with
FPHL or CTE have a negative pull test even if
they complain of excessive shedding. Other
more precise methods to assess hair shedding
are either semi-invasive (trichogram, phototri-
chogram) or very time consuming (wash test,
modified wash test) and difficult to utilize in the
office [16, 17]. A visual tool that could quickly
provide an idea of the hair shedding amount in
an office setting would aid the doctor’s and
patient’s assessment of hair loss. Two recent
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papers proposed and evaluated the efficacy of a
visual scale for evaluating hair shedding of
women. However, these scales were made for
women with thin blond straight hair [18, 19].
The aim of this study is to establish and validate
a hair-shedding scale for women with thick
curly hair of different lengths.
METHODS
All procedures followed were in accordance
with the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the Hel-
sinki Declaration of 1964, as revised in 2013.
Informed consent was obtained from all
patients for being included in the study.
A visual scale was developed for thick curly
hair of each hair length (shoulder, mid-back,
and lower back) by dividing a bundle of hairs of
each length into nine piles of increasing hair
amount (10, 50, 100, 200, 300, 400, 500, 600,
and 700 hairs) (Figs. 1, 2, 3). Each pile was
photographed and arranged in order of size. The
hairs were measured in thickness as well as
length. Due to the elliptical shape of hair, in
order to obtain a value of hair thickness the
cross-sectional area of the hairs was calculated.
Vivosight by Michelson Diagnostics Optical
Coherence Tomography was used to measure
the maximal and minimal diameters of the
hairs. Since hair has different thickness along
the shaft, proximal (A), medial (B), and distal
(C) levels were considered. The mean value for
A, B and C was used for this study.
Shoulder length hair had average thickness of
0.078 mmand length of 24.0 cm,medium length
hair had average thickness of 0.094 mm and
length of 32.5 cm, while long lower back hair had
average thickness1.06 mmand lengthof52.3 cm.
Hair curliness was evaluated using the visual
scale proposed by Loussouarn et al., which
defined hair curliness on a scale of I–VIII based
on simple measurements using curve diameter
meters and rulers [20]. The hairs utilized to
create the scale in our study were graded as type
III for all three different lengths.
To validate the scale, we showed a picture
with the scale to 20 asymptomatic women with
shoulder length hair, 20 asymptomatic women
with medium length hair, and 20 asymptomatic
women with lower back length hair. They were
asked to look at the nine photos and select the
photograph that best correlatedwith the amount
of hair they shed when brushing or combing on
an average shampooing day. Subjects were asked
to reevaluate their score 48 h later.
We also validated the scale in 94 women
with FPHL complaining of excessive shedding.
None of these patients had been treated before,
and diagnosis of FPHL was performed by clinical
examination and dermoscopy. Dermoscopic
pictures were taken in three scalp areas after
central parting (vertex, middle and frontal
scalp) at 920 and 940 magnification. FPHL
was diagnosed based on the presence of two
validated dermoscopic criteria: more than 20%
variability in the hair shaft diameter, and the
presence of more than seven short regrowing
hairs in the frontal scalp [21, 22]. These inclu-
ded 34 patients with shoulder length curly hair,
31 with medium length curly hair, and 29 with
long curly hair. Patients were asked to score
their hair loss using the scale on their first visit,
as well as 1 week later. Patients were consecu-
tively recruited during a 5-month period.
To validate if patient’s perception of shed-
ding from the scale correlated with the actual
hairs shed, we manually counted the hairs from
two additional women with medium length
hair affected by FPHL and excessive shedding,
who were not part of the original study. These
patients were asked to shampoo every other day
for 2 weeks and to bring the hairs shed during
each shampoo in separate bags after grading the
amount of shedding using the scale.
RESULTS
Results of the shedding scores for normal
women not complaining of hair shedding and
women with FPHL complaining of excessive
shedding are summarized in Tables 1 and 2.
Normal Women (Table 1)
Normal women with shoulder hair had a mean
shedding score of 2.50, Spearman’s q coefficient
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Fig. 1 Shedding scale short length hair (1:1)
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Fig. 2 Shedding scale medium length hair (1:1)
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Fig. 3 Shedding scale long hair (1:1)
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0.955 (p\0.0001) and j 0.927 (p\0.0001).
Normal women with medium length hair had a
mean shedding score of 2.35, Spearman’s q
coefficient 0.978 (p\0.0001) and j 0.932
(p\0.0001). Normal women with long hair had
a mean shedding score of 2.40, Spearman’s q
coefficient 0.956 (p\0.0001) and j 0.927
(p\0.0001). j was excellent in each of the
groups of normal women.
Female Pattern Hair Loss (Table 2)
Women with FPHL and shoulder hair had a
mean shedding score of 7.25, Spearman’s q
coefficient 0.986 (p\0.0001) and j 0.963
(p\0.0001). Data are reported in detail in
Table 2. Women with FPHL and medium length
hair had a mean shedding score of 7.0, Spear-
man’s q coefficient 0.994 (p\0.0001) and
j 0.920 (p\0.0001). Women with FPHL and
long hair had a mean shedding score of 7.14,
Spearman’s q coefficient 0.990 (p\0.0001) and
j 0.956 (p\0.0001).
Manual Hair Count
Table 3 reports the results of the manual hair
count of 15 samples. Statistical analysis showed
strong correlation between shedding score and
manual counting. Pearson correlation 0.88,
p\0.05.
DISCUSSION
Female patients with hair loss of different causes
frequently come to the office with pictures or
even bags of hairs to document their problem. It
Table 1 Hair-shedding scale results, healthy women
Hair-shedding score Number of patients that chose the corresponding hair-shedding score
Short hair Medium-length hair Long hair
1st visit 2nd visit 1st visit 2nd visit 1st visit 2nd visit
Hair-shedding score in patients without FPHL
1 2 2 5 5 3 3
2 9 8 6 6 8 7
3 6 7 6 7 7 8
4 3 3 3 2 2 2
5 0 0 0 0 0 0
6 0 0 0 0 0 0
7 0 0 0 0 0 0
8 0 0 0 0 0 0
9 0 0 0 0 0 0
Total 20 20 20
Mean ± SD 2.50 ± 0.8 2.55 ± 0.8 2.35 ± 1.0 2.40 ± 0.9 2.40 ± 0.8 2.45 ± 0.8
q Spearman 0.955 \0.978 0.956
p value \0.0001 \0.0001 \0.0001
j 0.927 0.932 0.927
p value \0.0001 \0.0001 \0.0001
Hair-shedding score: 1–4 normal hair shedding, 5–9 excessive hair shedding
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is, therefore, important for dermatologists who
are not specialized in hair disorders to have a
fast tool that allows them to distinguish normal
from abnormal. The hair-shedding scale is, in
our opinion, the best instrument to feed this
need. In fact, the time required to explain the
scale to the patient and to obtain the patient’s
perception of shedding by looking at the scale
was always within 2 min.
The hair-shedding scale is not a diagnostic
instrument, as excessive hair shedding can be a
symptom of numerous hair disorders, but it is a
tool that helps in discriminating normal from
excessive shedding in a busy office practice. It
should be utilized together with other objective
diagnostic methods, particularly trichoscopy,
which are essential in identifying early FPHL.
Although not validated in the present study, the
scale could also allow doctors to roughly estab-
lish the amount of hair that is shed when
patients bring bags of hair to the office. Fre-
quency of shampooing and brushing habits can
definitely influence the amount of shedding,
and should always be considered when evalu-
ating results.
Our hair-shedding scale is designed for Cau-
casian women with thick hair, and the thick-
ness of the hair fibers utilized to create the scale
correlate well with the reported thickness of
Caucasian thick hair [23]. It well complements
the scale that has already been validated for
Caucasian women with blond thin hair. A dif-
ferent scale needs to be created for women of
Asian or African ethnicity.
This hair-shedding visual scale showed an
excellent observable correlation and
Table 2 Hair-shedding scale results, FPHL women
Hair-shedding score Number of patients that chose the corresponding hair-shedding score
Short hair Medium-length hair Long hair
1st visit 2nd visit 1st visit 2nd visit 1st visit 2nd visit
Hair-shedding score FPHL patients
1 0 0 1 1 0 0
2 1 1 1 1 2 2
3 1 1 0 0 1 1
4 1 1 1 1 1 1
5 2 2 2 2 1 1
6 3 3 4 4 2 2
7 7 7 5 6 6 7
8 10 9 7 8 7 6
9 9 10 8 8 9 9
Total 34 31 29
Mean ± SD 7.25 ± 1.7 7.29 ± 1.8 7.0 ± 2.0 7.06 ± 2.0 7.14 ± 2.1 7.10 ± 2.0
q Spearman 0.986 0.994 0.990
p value \0.0001 \0.0001 \0.0001
j 0.963 0.920 0.956
p value \0.0001 \0.0001 \0.0001
Hair-shedding score: 1–4 normal hair shedding, 5–9 excessive hair shedding
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concordance in both healthy women and
women with excessive hair shedding. Women
with no FPHL had a statistically significant
lower score of hair shedding in the visual scale
than women with FPHL. All healthy women
had a score of 1–4, which would be considered
as normal hair shedding. Mean values were
within 2 and 3, showing that most women not
complaining of hair loss graded their shedding
as less than 100 hairs.
For women with FPHL, 91% of women with
shoulder hair, 90% of women with med-
ium-length hair and 86% of women with long
hair chose images 5–9 which correspond to
excessive hair shedding. These results are in
accordance with the results of a recent study on
the prevalence of hair shedding in females not
suffering from FPHL using the published visual
analog scale. This study found that 60% of
women (21 out of 37) with FPHL reported
excessive hair shedding versus 40% of women
(104 out of 263) without FPHL on hair washing
days [19]. In this study, excessive shedding was
found to be inversely proportional to age, while
being strongly correlated with hair length, as
most of the subjects who reported excessive
shedding had hair longer than shoulder length.
These results point out that a single scale is not
able to accurately assess shedding and that
scales for different hair length are needed.
One possible limitation of this study is that
women who believe they have excess hair shed-
dingmaybemore likely to choosehair bundles at
the higher end of the scale compared to those
who do not perceive the same extent of hair loss;
however, we believe this does not change the
usefulness of the scale in clinical practice. The
scale should not be used as a precise measure of
hair loss but instead as a tool to quickly distin-
guish normal from abnormal. Although we
decided to provide a 9-grade scale, differences
within the very abnormal ranges might not pos-
sibly be detected. However, our manual count
results indicate that perception of shedding was
quite accurate within grades. Other factors, par-
ticularly psychological factors such as anxious
preoccupation, helplessness, and feelings of
diminished attractiveness, can also drive the
perceptionof hair loss and are known to co-occur
with hair shedding in women [24].
CONCLUSIONS
The hair-shedding visual scale is a fast and
effective method of evaluating hair-shedding
amount as well as the patient’s perception of
hair shedding. Using the visual scale, doctors
and patients will be able to grossly estimate
hair loss severity before and after treatment.
In this study, we did not evaluate the use of
the scale in assessing response to treatments,
but we think that the scale can become a part
of the tools that we use to gauge a patient’s
progression with therapy. Ongoing use of this
scale may be valuable in evaluating response
to therapy as well as decreasing patient
Table 3 Correlations between scale results and manual
counting in 14 samples from 2 women
Day Visual scale Manual count
1 5 (300) 275 Patient 1
2 6 (400) 380
3 5 (300) 307
4 5 (300) 296
5 7 (500) 435
6 6 (400) 366
7 5 (300) 271
8 5 (300) 310
1 4 (200) 163 Patient 2
2 6 (400) 432
3 5 (300) 330
4 3 (100) 215
5 6 (400) 382
6 5 (300) 315
7 5 (300) 367
Pearson 0.88
p value \0.05
The visual scale is indicated as a numerical grade followed
by numerical value in parenthesis
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anxiety, as they will be able to objectively
assess their treatment response. This scale is a
quick and simple tool that can be used in an
office setting and is effective in patients of all
hair lengths including short, medium, and
long length thick hair.
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